Clinical Trial Update: Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II [Phase 2]

View source ↗

Summary

Phase II trial evaluating the safety and potential neuroprotective effects of Polyphenon E in multiple sclerosis. The study was terminated, and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Polyphenon E (sinecatechin)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2014-03-14